Advertise here
Advertise here
Headlines

Researchers discover compounds produced by gut bacteria that can treat inflammation

Non-enzymatic production of diindoles. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-46559-3 Researchers at the University of Toronto have found naturally occurring compounds in the gut that can be harnessed to reduce inflammation and other symptoms of digestive issues. This can be achieved by binding the compounds to an important, but poorly understood, nuclear receptor. The gut…

Read More

iGlarLixi Safe and Effective in Inadequately Controlled T2D

TOPLINE: iGlarLixi, a fixed-ratio combination of insulin glargine and the glucagon-like peptide-1 receptor agonist (GLP-1 RA) lixisenatide, improves glycemic control, with a low rate of hypoglycemia, in adults with inadequately controlled type 2 diabetes (T2D). METHODOLOGY: The 2022 Consensus Statement from the American Diabetes Association/European Association for the Study of Diabetes suggests that a fixed-ratio…

Read More

Therapist Burnout Negatively Affects Patient Outcomes During Psychotherapy

Therapist burnout negatively affected the delivery of trauma-focused psychotherapies (TFPs) to patients with posttraumatic stress disorder (PTSD), according to study results published in JAMA Network Open. Clinicians who experience burnout have previously reported that their symptoms affect the quality of care they deliver, their communication with patients, and the likelihood of making a medical error….

Read More

Change Eligibility Rules for More Diverse Clinical Trials?

Expanding eligibility criteria is a strategy for improving the inclusion of traditionally underrepresented populations in clinical trials, according to a study. The results were published in NEJM Evidence by Maneet Kaur, PhD, epidemiologist and senior scientist at Flatiron Health, New York, and colleagues. Flatiron Health is an independent member company of the Roche group and…

Read More

Amgen obesity drug MariTide: four key questions going forward

Amgen’s comments Thursday that it’s “very encouraged” by interim Phase 2 data for its obesity drug have quickly sparked immense investor interest in what could be a potential contender with Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The injectable drug MariTide, designed to be given monthly, could be a more attractive option than Wegovy and…

Read More

New approach for developing cancer vaccines could make immunotherapies more effective in acute myeloid leukemia

UChicago Pritzker School of Molecular Engineering PhD candidate Anna Slezak is first author on recent paper on developing in-situ cancer vaccines could make immunotherapies more effective in the blood cancer acute myeloid leukemia and other blood cancers. Credit: Ryne Montoya Acute myeloid leukemia (AML) is a type of blood cancer that forms in the soft…

Read More

Inflammatory disease not major risk factors for severe COVID-19, focus on comorbidities urged

In a recent study published in The Lancet Digital Health, a group of researchers analyzed severe coronavirus disease 2019 (COVID-19) outcomes in patients with immune-mediated inflammatory diseases (IMIDs), focusing on the effects of medications, comorbidities, and vaccination status during different pandemic phases. Study: Machine learning to understand risks for severe COVID-19 outcomes: a retrospective cohort study…

Read More

Jump-Start Your Exercise With This Mindset Reset

May 3, 2024 – There are plenty of reasons to exercise, but some are more motivating than others.  Perhaps the sexiest motivator – and the one people tend to go with, especially with warm weather around the corner – is to build the “beach body.”  The problem: Setting big expectations for weight loss can position…

Read More

MicroRNAs Predict Pancreatic Cancer Risk Years in Advance

TOPLINE: Researchers have identified specific circulating microRNAs (miRNAs) in blood samples that can identify individuals at high risk of developing pancreatic cancer within 5 years, potentially improving early detection and outcomes. METHODOLOGY: Early detection of pancreatic cancer could improve patient prognosis, but clinically viable biomarkers are lacking. In a two-stage study, researchers screened and validated…

Read More

Profluent releases AI-enabled OpenCRISPR-1 to edit the human genome

AI-enabled protein design company Profluent has leveraged artificial intelligence to design an open-source gene editor called OpenCRISPR-1, demonstrating the technology can be used to create molecules with the power to edit human DNA. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology, developed more than a decade ago, allows scientists to modify DNA sequences within living…

Read More

How cancer cells harness energy to drive disease progression

The Warburg effect and metabolic rewiring. Credit: Cancer Biology & Medicine Researchers have revealed crucial insights into how the Warburg effect causes the dedifferentiation of cancer cells through epigenetic reprogramming. This discovery potentially opens up new avenues for cancer treatments that target cellular metabolism. A century after Otto Warburg first described the phenomenon where cancer…

Read More

Amgen, Illumina, Novo Nordisk, and more

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning! A crowdsourced Readout today, to be sure, with contributions from STAT’s Jason Mast, Elaine Chen, and Jonathan Wosen. We get into earnings from Novo Nordisk, Amgen, and Illumina, and see…

Read More

Chronic Spontaneous Urticaria: What to Know

Chronic spontaneous urticaria (CSU) can make you feel itchy and uncomfortable. It causes hives that come and go unexpectedly. You probably wonder why you get them and what to do about them.There’s no clear cause of chronic spontaneous urticaria, or chronic hives, but you and your doctor can manage it.“When I diagnose a patient with…

Read More

NIH develops AI tool to better pair cancer patients with drugs

Researchers at the National Cancer Institute have developed an AI tool, PERCEPTION, that predicts patient responses to cancer treatment drugs using individual tumor cells. This approach provides better resolution data by utilizing single-cell RNA sequencing. The tool showed promise in clinical trials for myeloma and breast cancer by ranking drug combinations based on individual tumor…

Read More

Medical Providers Still Grappling With UnitedHealth Cyberattack: ‘More Devastating Than Covid’

Medical providers are still struggling after a cyberattack on a UnitedHealth Group subsidiary disrupted payments. The digital network affected processes a significant number of U.S. patient records. Providers are facing difficulties in receiving payments and managing billing without the electronic remittance information. The cyberattack has cost UnitedHealth $870 million with a total expected cost of…

Read More

OTC birth control ‘a tremendous advance’ in women’s health, with important caveats

Presenters at the ACP’s annual meeting discussed a new over-the-counter birth control option, norgestrel 0.075 mg (Opill), which is less effective than other options but important for women without health insurance. The presentation highlighted the importance of counseling patients on the pill’s history, side effects, and effectiveness, as well as the need to continue using…

Read More

Tumor deposits in colorectal and gastric cancers

Tumor deposits (TDs) are clusters of tumor cells found in adipose and fibrous tissues near the primary tumor in various cancers, including colorectal and gastric cancer. They lack lymphoid structures and are not directly linked to the primary tumor. The 8th edition of TNM staging defines TDs as tumor cell deposits without identifiable vascular or…

Read More

New AI tool ‘TORCH’ successfully identifies cancer origins in unknown primary cases

Researchers developed the TORCH deep-learning approach to differentiate tumor origins using cytological histology pictures from over 57,000 patients with hydrothorax and ascites. The AI model showed high accuracy in predicting cancer origin compared to pathologists. TORCH improved junior pathologists’ diagnostic abilities and guided treatment choices, leading to better overall survival rates in patients. The model…

Read More

Hate Taking Pills? For Some Drugs, You Won’t Need To

Buccal patches stuck to the inside of the mouth offer a quicker and potentially side effect-free way to deliver drugs, especially for those who struggle with swallowing pills or insulin injections. Buccal films and patches are developing as innovative methods of drug administration, providing benefits such as rapid onset of action, avoidance of gastrointestinal side…

Read More

Hospice Handoffs May Lower Odds of Medicare Denials

Better communication between primary care clinicians and hospice providers can reduce the number of denied Medicare approvals for end-of-life treatment. Dr. Tyler Haussler conducted a study showing that poor documentation by physicians often leads to denials by CMS. Having a face-to-face conversation between the referring physician and hospice medical director improved the quality of documentation…

Read More

Build Your Dream Skincare Regimen

Korean sunscreens are revolutionizing sun care by offering innovative formulas that go beyond basic sunblock to provide multiple skincare benefits. These sunscreens have cutting-edge formulations, lightweight textures, and high levels of sun protection, making them a pleasure to wear and incorporate into your daily routine. Factors to consider when choosing a Korean sunscreen include broad-spectrum…

Read More

Non-thermal atmospheric-pressure plasma novel approach to treatment of bone fractures: Study

A recent study explores the use of non-thermal atmospheric-pressure plasma as a novel approach for treating bone fractures. This method shows promise in promoting bone healing and regeneration. The study highlights the potential benefits of using this technique in the treatment of fractures, offering an alternative to traditional methods. Researchers are continuing to investigate the…

Read More

Ilant Health Raises Extended Seed Round of $5.5M for Obesity Management Platform

Ilant Health, a virtual obesity management company, extended its seed funding round from $3 million to $5.5 million. Based in New York City, the company provides value-based care to employers and government payers nationwide. They match patients to personalized obesity treatment options such as intensive behavioral therapy, pharmacotherapy, and bariatric surgery. The funding includes participation…

Read More

Dr Anthony Fauci receives honours on Irish visit 

In a special ceremony, renowned immunologist Dr. Anthony Fauci was awarded an honorary fellowship by the UCD School of Medicine and received the Fulbright Ireland Public Service Award for his outstanding contributions to public service. Dr. Fauci, who served as director of the U.S. National Institute of Allergy and Infectious Diseases, has been a key…

Read More

In San Francisco’s Chinatown, a CEO Works With the Community To Bolster Hospital

Chinese Hospital in San Francisco, located in Chinatown, faces financial challenges common in underserved areas. Many patients are elderly with limited incomes and rely on Medicare and Medi-Cal. The hospital receives lower reimbursement rates due to a federal rule and struggles with high costs. Despite this, it has strong community support and partnerships. Fundraising efforts…

Read More

Takeda’s Entyvio snags second FDA approval as ‘subcutaneous option’ for Crohn’s disease

The FDA has approved the subcutaneous administration of Takeda Pharmaceuticals’ Entyvio for maintenance therapy in adult patients with moderate-to-severe Crohn’s disease after induction therapy via IV administration. The approval was based on the results of a phase 3 clinical trial, VISIBLE 2, which showed that patients who received SC vedolizumab achieved higher rates of clinical…

Read More

New AI tool enhances medical imaging with deep learning and text analysis

Researchers developed the MONET foundation model to connect medical images to text based on medically relevant ideas, aiding in medical AI development. They collected over 100,000 dermatology image-text pairs to train MONET to identify various concepts in dermatological images. MONET’s concept annotation capabilities were evaluated by comparing its performance to other models and used for…

Read More
Advertise here
error: Content is protected !!